News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
869,409 Results
Type
Article (87918)
Company Profile (825)
Press Release (780650)
Multimedia
Podcasts (192)
Webinars (28)
Section
Business (233246)
Career Advice (4145)
Deals (39870)
Drug Delivery (146)
Drug Development (91403)
Employer Resources (204)
FDA (18380)
Job Trends (17424)
News (397868)
Policy (39961)
Tag
Academia (3007)
Academic (2)
Accelerated approval (33)
Adcomms (36)
Allergies (144)
Alliances (56981)
ALS (180)
Alzheimer's disease (1785)
Antibody-drug conjugate (ADC) (337)
Approvals (18550)
Artificial intelligence (615)
Autoimmune disease (155)
Automation (35)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (199)
Biotechnology (490)
Bladder cancer (161)
Brain cancer (64)
Breast cancer (649)
Cancer (4947)
Cardiovascular disease (436)
Career advice (3567)
Career pathing (40)
CAR-T (302)
CDC (59)
Celiac Disease (1)
Cell therapy (818)
Cervical cancer (37)
Clinical research (76917)
Collaboration (1761)
Company closure (5)
Compensation (1136)
Complete response letters (70)
COVID-19 (2989)
CRISPR (97)
C-suite (830)
Cystic fibrosis (154)
Data (6164)
Decentralized trials (2)
Denatured (70)
Depression (148)
Diabetes (528)
Diagnostics (7209)
Digital health (44)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (297)
Drug pricing (220)
Drug shortages (36)
Duchenne muscular dystrophy (234)
Earnings (100046)
Editorial (61)
Employer branding (25)
Employer resources (173)
Events (134982)
Executive appointments (1026)
FDA (21476)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1533)
Gene editing (211)
Generative AI (63)
Gene therapy (661)
GLP-1 (1111)
Government (5432)
Grass and pollen (8)
Guidances (383)
Healthcare (20942)
HIV (60)
Huntington's disease (48)
IgA nephropathy (86)
Immunology and inflammation (287)
Immuno-oncology (56)
Indications (84)
Infectious disease (3273)
Inflammatory bowel disease (203)
Inflation Reduction Act (17)
Influenza (118)
Intellectual property (240)
Interviews (816)
IPO (17953)
IRA (60)
Job creations (5199)
Job search strategy (2866)
Kidney cancer (17)
Labor market (90)
Layoffs (658)
Leadership (39)
Legal (10158)
Liver cancer (98)
Longevity (14)
Lung cancer (674)
Lymphoma (372)
Machine learning (43)
Management (66)
Manufacturing (823)
MASH (171)
Medical device (15003)
Medtech (15047)
Mergers & acquisitions (22960)
Metabolic disorders (1371)
Multiple sclerosis (158)
NASH (23)
Neurodegenerative disease (343)
Neuropsychiatric disorders (93)
Neuroscience (3074)
NextGen: Class of 2026 (7707)
Non-profit (5110)
Now hiring (63)
Obesity (660)
Opinion (331)
Ovarian cancer (164)
Pain (200)
Pancreatic cancer (227)
Parkinson's disease (289)
Partnered (39)
Patents (493)
Patient recruitment (461)
Peanut (60)
People (66826)
Pharmaceutical (145)
Pharmacy benefit managers (31)
Phase I (23774)
Phase II (33370)
Phase III (25159)
Pipeline (4746)
Policy (330)
Postmarket research (3554)
Preclinical (10685)
Press Release (72)
Prostate cancer (240)
Psychedelics (53)
Radiopharmaceuticals (298)
Rare diseases (873)
Real estate (7437)
Recruiting (80)
Regulatory (28896)
Reports (66)
Research institute (2721)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (20)
RSV (83)
Schizophrenia (157)
Series A (254)
Series B (193)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (176)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (112)
Tariffs (98)
The Weekly (120)
Vaccines (1132)
Venture capital (92)
Weight loss (456)
Women's health (85)
Worklife (21)
Date
Today (83)
Last 7 days (372)
Last 30 days (2061)
Last 365 days (33196)
2026 (1722)
2025 (33226)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (88)
Alaska (7)
Arizona (339)
Arkansas (14)
Asia (51508)
Australia (9038)
California (11352)
Canada (3277)
China (1142)
Colorado (479)
Connecticut (495)
Delaware (342)
Europe (118328)
Florida (1659)
Georgia (366)
Hawaii (3)
Idaho (68)
Illinois (947)
India (66)
Indiana (537)
Iowa (24)
Japan (416)
Kansas (132)
Kentucky (42)
Louisiana (29)
Maine (83)
Maryland (1443)
Massachusetts (8400)
Michigan (352)
Minnesota (654)
Mississippi (6)
Missouri (138)
Montana (35)
Nebraska (29)
Nevada (123)
New Hampshire (85)
New Jersey (3069)
New Mexico (33)
New York (3008)
North Carolina (1588)
North Dakota (10)
Northern California (5413)
Ohio (349)
Oklahoma (22)
Oregon (54)
Pennsylvania (2278)
Puerto Rico (21)
Rhode Island (50)
South America (1657)
South Carolina (63)
South Dakota (1)
Southern California (4375)
Tennessee (174)
Texas (1792)
United States (41081)
Utah (341)
Vermont (1)
Virginia (285)
Washington D.C. (86)
Washington State (957)
West Virginia (4)
Wisconsin (123)
Wyoming (2)
There are 869,409 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Insilico Medicine and Hygtia Therapeutics Enter New Global Strategic Collaboration to Co-Develop Novel Brain Penetrant NLRP3 Inhibitor for CNS Diseases treatment
January 20, 2026
·
1 min read
Press Releases
Rosalind Franklin University Researcher Awarded $1.9M NIH Grant for Neurological Disease Research
January 20, 2026
·
1 min read
Press Releases
Nocturia Market Poised for Rapid Growth, Expected to Reach USD 7.61 Billion by 2032 | Coherent Market Insights
January 20, 2026
·
1 min read
Press Releases
Atopia Therapeutics Reports Preclinical Proof-of-Concept of Lead Compound ATP-R13 in Atopic Dermatitis and Strengthens Patent Protection
- Preclinical in vivo efficacy data in atopic dermatitis extend previous PoC in allergic asthma - Positive opinion from the European Patent Office strengthens patent protection of ATP-R13 - Progress significantly enhances the strategic attractiveness of ATP-R13 as a broadly applicable, disease-modifying therapy across multiple allergic indications
January 20, 2026
·
1 min read
Press Releases
20n Bio and Lannacheng Announced Strategic Partnership to Advance Next-Generation Radionuclide Drug Conjugates
January 20, 2026
·
1 min read
Press Releases
Phio Pharmaceuticals Announces Key Tumor Response Data from all Cohorts in Intratumoral PH-762 Dose Escalation Cutaneous Carcinoma Trial
January 20, 2026
·
1 min read
Press Releases
BioVaxys Reports Positive Clinical Study Results from Phase 1B/2 PESCO Trial of MVP-S with Pembrolizumab (Keytruda (TM)) and Low-Dose Cyclophosphamide for Patients with Recurrent Epithelial Ovarian Cancer (EOC)
January 20, 2026
·
1 min read
Press Releases
Therma Bright Sells an Additional 200-Units of Venowave(TM) to Strategic Distribution Partner Gen-X Med
January 20, 2026
·
1 min read
Press Releases
Aminoglycosides Market Size to worth US$ 3.09 Billion by 2033, Coherent Market Insights
January 20, 2026
·
1 min read
Press Releases
Mpac Lambert Partners with GlucoModicum to Deliver Scalable Automation for Needle-Free Glucose Monitoring Sensor
Mpac Lambert is delivering a fully automated, ultra-high-volume line for GlucoModicum’s needle-free glucose sensor Sofio - providing sub-second cycle time, medical-grade precision, and scalable capacity of 21 million units per year, supported by two years of industrial-scale proof-of-principle work.
January 20, 2026
·
1 min read
1 of 86,941
Next
